Notify me when Hillman Capital Management, Inc. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 53 | $171,848,541 | +$17,432,218 | -$35,596,945 | -$18,164,727 | ASML, WBD, EL, CVS, BA | 13F-HR | 14 Nov 2025, 09:00 |
| Q2 2025 | 50 | $183,256,760 | +$4,264,390 | -$26,869,742 | -$22,605,352 | T, WBD, BA, EL, MSFT | 13F-HR | 14 Aug 2025, 09:00 |
| Q1 2025 | 51 | $203,250,574 | +$16,372,925 | -$78,808,246 | -$62,435,321 | T, WBD, CVS, ZBH, KMX | 13F-HR | 15 May 2025, 09:00 |
| Q4 2024 | 54 | $269,556,764 | +$37,772,556 | -$44,903,914 | -$7,131,358 | AMZN, T, BA, WBD, KMX | 13F-HR | 14 Feb 2025, 09:00 |
| Q3 2024 | 52 | $291,577,167 | +$18,080,789 | -$19,170,373 | -$1,089,584 | IFF, MSFT, T, DD, SPG | 13F-HR | 14 Nov 2024, 09:00 |
| Q2 2024 | 53 | $283,225,526 | +$20,111,364 | -$30,999,302 | -$10,887,938 | MSFT, AMZN, IFF, WFC, SPG | 13F-HR | 14 Aug 2024, 09:00 |
| Q1 2024 | 52 | $311,166,790 | +$34,946,024 | -$28,481,046 | +$6,464,978 | TSM, MSFT, WFC, AMZN, KMX | 13F-HR | 15 May 2024, 09:00 |
| Q4 2023 | 53 | $289,651,223 | +$23,294,663 | -$28,991,492 | -$5,696,829 | SPG, MSFT, ASML, BA, INTC | 13F-HR | 14 Feb 2024, 09:00 |
| Q3 2023 | 53 | $259,748,840 | +$25,205,269 | -$33,731,638 | -$8,526,369 | MSFT, BIIB, WFC, IFF, GSK | 13F-HR | 14 Nov 2023, 09:00 |
| Q2 2023 | 55 | $283,314,754 | +$13,355,814 | -$5,121,706 | +$8,234,108 | MSFT, AMZN, TSM, ASML, WFC | 13F-HR | 14 Aug 2023, 09:00 |
| Q1 2023 | 52 | $264,276,619 | +$6,474,432 | -$15,943,311 | -$9,468,879 | BUD, MSFT, TSM, ASML, EPD | 13F-HR | 15 May 2023, 09:00 |
| Q4 2022 | 52 | $254,510,091 | +$10,188,845 | -$22,365,807 | -$12,176,962 | BUD, WFC, KHC, BA, CVS | 13F-HR | 14 Feb 2023, 09:00 |
| Q3 2022 | 48 | $240,889,000 | +$25,103,297 | -$30,771,365 | -$5,668,068 | CVS, WFC, MSFT, BIIB, K | 13F-HR | 14 Nov 2022, 09:00 |
| Q2 2022 | 48 | $275,261,000 | +$33,638,646 | -$23,631,300 | +$10,007,346 | K, T, KHC, GSK, MSFT | 13F-HR | 15 Aug 2022, 08:01 |
| Q1 2022 | 48 | $314,991,000 | +$51,034,710 | -$27,629,190 | +$23,405,520 | KHC, GSK, K, BMY, AMZN | 13F-HR | 16 May 2022, 09:28 |
| Q4 2021 | 54 | $290,859,000 | +$17,353,723 | -$17,196,990 | +$156,733 | SPG, CVS, WFC, MSFT, GSK | 13F-HR | 14 Feb 2022, 08:53 |
| Q3 2021 | 51 | $284,767,000 | +$44,395,343 | -$11,542,028 | +$32,853,315 | WFC, SPG, BA, KHC, AMZN | 13F-HR | 15 Nov 2021, 09:21 |
| Q2 2021 | 48 | $262,807,000 | +$18,015,944 | -$304,757 | +$17,711,187 | WFC, AMZN, XOM, SPG, PAA | 13F-HR | 16 Aug 2021, 09:11 |
| Q1 2021 | 43 | $227,997,000 | +$59,804,544 | -$35,700,729 | +$24,103,815 | WFC, XOM, K, KHC, BA | 13F-HR | 14 May 2021, 08:49 |
| Q4 2020 | 46 | $185,242,000 | +$19,983,212 | -$4,415,781 | +$15,567,431 | JWN, DD, MSFT, WFC, KHC | 13F-HR | 12 Feb 2021, 08:33 |
| Q3 2020 | 36 | $142,088,000 | +$22,039,331 | -$16,111,926 | +$5,927,405 | MSFT, INTC, CMP, BIIB, DD | 13F-HR | 09 Nov 2020, 11:45 |
| Q2 2020 | 38 | $137,279,000 | +$21,877,086 | -$5,001,571 | +$16,875,515 | AMZN, MSFT, DD, KHC, K | 13F-HR | 04 Aug 2020, 10:57 |
| Q1 2020 | 36 | $104,413,000 | +$13,667,251 | -$15,784,785 | -$2,117,534 | AMZN, BIIB, MSFT, BMY, K | 13F-HR | 29 Apr 2020, 16:07 |
| Q4 2019 | 50 | $141,107,000 | $0 | $0 | $0 | JWN, MSFT, BMY, BIIB, T | 13F-HR | 14 Feb 2020, 10:44 |
| Q4 2013 | 38 | $66,891,000 | $0 | $0 | $0 | RTN, AXP, BAC, AAPL, GS | 13F-HR | 07 Feb 2014, 13:16 |